Li M., Zhao C., Xiang H., Wang Y., Gao R., Cai Q., Chen Q., Chen Z., Hu L., Li Q. Design, synthesis and optimization of pyrazolo[3,4-b] pyridine derivatives as Hsp110-STAT3 interaction disruptors for the treatment of pulmonary arterial hypertension. Bioorg Chem, 2024, 153: 107888.
Hits:
|
Pre One:Li J., Gao R., Zhao C., Xiang H., Le X., Zhang X., Cai Q., He L., Li Q., Hu L., Zou H. Inhibition of breast cancer growth with AN-329, a novel Hsp110 inhibitor, by inactivating p-STAT3/c-Myc axis. Biomed. Pharmacother., 2024, 181: 117694.
Next One:Guo Y., Cao M., Li Z., Zhou H., Chen Z., Li Q. Discovery of a novel 2,4-thiazolidinedione derivative as dual inhibitor of beta-catenin/TCF4 interaction and tubulin polymerization in colon cancer cells. Arch Pharm (Weinheim), 2025, 358(3): e2400796.
